Association of ALS to gene-environment mediated changes in HDL proteins
ALS 与基因环境介导的 HDL 蛋白变化的关联
基本信息
- 批准号:8422569
- 负责人:
- 金额:$ 24.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-01 至 2017-10-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAmyotrophic Lateral SclerosisAnabolismAnimalsApolipoproteinsArchivesBloodC9ORF72Cardiovascular DiseasesCell Culture TechniquesCellsCerebrospinal FluidCholesterolCollectionDNA ResequencingDataDiseaseElderlyEnvironmentEnzyme GeneEnzymesEtiologyEventFamilial diseaseFatty acid glycerol estersFunctional disorderGenderGene ClusterGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenetic PolymorphismGenetically Engineered MouseGenetically Modified AnimalsGenomeGenotypeHigh Density LipoproteinsHomeostasisHumanInflammationInsecticidesLaboratoriesLeadLinkLipidsLipoproteinsLow-Density LipoproteinsMass Spectrum AnalysisMeasuresMediatingMetabolic DiseasesMethodologyMethodsMusMutationNerve DegenerationNeuraxisNeurodegenerative DisordersNeuronsPancreasPatientsPesticidesPhysiologyPlasmaProcessProteinsProteomeRaceRiskSamplingSerumSingle Nucleotide PolymorphismSiteSuperoxide DismutaseTechniquesTestingTimeTissuesTrainingTransgenic ModelVariantWorkaryldialkylphosphatasebasecase controlcohortgenetic associationgenetic varianthigh throughput technologymiddle ageoxidationoxidative damageoxidized lipidparticleprospectiveprotein TDP-43protein functionpublic health relevanceresponserodent genomestressorubiquilinvector
项目摘要
DESCRIPTION (provided by applicant): Amyotrophic lateral sclerosis (ALS) or Lou Gehrig disease is a fatal neurodegenerative disease that primarily affects mid-life and older adults. There are two forms of disease, familial (FALS) and sporadic (SALS), respectively comprising 10% and 90% of cases, respectively. The genetic causes of FALS have been linked to mutations in several genes such as superoxide dismutase, TDP-43, FUS, optineurin, ubiquilin 2 and C9ORF72. The etiology of SALS, however, remains elusive. A few years ago our laboratory found that there were polymorphisms in genes for enzymes called paraoxonases that were associated with SALS. These enzymes detoxify certain pesticides and toxic agents, and thus became the first environmentally related genes linked to ALS. Further studies of the paraoxonases and apolipoprotein L1 in the plasma indicate that their levels are significantly elevated in SALS patients. These proteins are found on specific high density lipoprotein (HDL) particles that have several functions including lipid and cholesterol transport and protecting lipoproteins from deleterious oxidation. Similar particles are also found in the cerebrospinal flui (CSF). Thus, in this proposal we further characterize the protein composition of selected HDL species in the plasma and CSF of SALS patients using high throughput technologies. We can now, for the first, time determine how certain HDL proteins change in a neurodegenerative disease and if they are linked to the disease process. We will also determine whether the genes for HDL-associated proteins contain variants that are associated with risk of SALS and whether these changes are related to alterations in HDL protein levels. Mechanisms of the deleterious effects of these changes will be studied in cell culture and genetically engineered mice. Results from this work will open paths to therapies to rescue potential dysfunctional HDL found not only in neurodegenerative disease such as ALS but also in more common cardiovascular and metabolic diseases.
描述(由申请人提供):肌萎缩性侧面硬化症(ALS)或Lou Gehrig病是一种致命的神经退行性疾病,主要影响中年和老年人。分别有两种形式的疾病,家族性(fals)和零星(SALS),分别占病例的10%和90%。 fal的遗传原因与多种基因的突变有关,例如超氧化物歧化酶,TDP-43,FUS,Optineurin,ubiquilin 2和C9orf72。然而,萨尔的病因仍然难以捉摸。几年前,我们的实验室发现,称为二氧蛋白酶的酶的基因中存在多态性,与sals相关。这些酶对某些农药和有毒剂排毒,因此成为与ALS相关的第一个与环境相关的基因。在血浆中对二氧蛋白酶和载脂蛋白L1的进一步研究表明,盐患者的水平显着升高。这些蛋白质是在具有多种功能在内的特定高密度脂蛋白(HDL)颗粒上发现的,包括脂质和胆固醇转运,并保护脂蛋白免受有害氧化的影响。在脑脊液(CSF)中也发现了类似的颗粒。因此,在此提案中,我们进一步表征了使用高通量技术在萨尔氏菌患者的血浆和CSF中选定的HDL物种的蛋白质组成。现在,我们可以在第一个时间确定神经退行性疾病中某些HDL蛋白的变化以及它们是否与疾病过程有关。我们还将确定HDL相关蛋白的基因是否包含与SALS风险相关的变体,以及这些变化是否与HDL蛋白水平的改变有关。这些变化的有害影响的机制将在细胞培养和基因工程小鼠中进行研究。这项工作的结果将开辟疗法的途径,以挽救潜在的功能障碍HDL,不仅在神经退行性疾病(例如ALS)中发现,而且在更常见的心血管和代谢疾病中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TEEPU SIDDIQUE其他文献
TEEPU SIDDIQUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TEEPU SIDDIQUE', 18)}}的其他基金
A novel innate immunity risk factor for amyotrophic lateral sclerosis
肌萎缩侧索硬化症的新先天免疫危险因素
- 批准号:
10220811 - 财政年份:2019
- 资助金额:
$ 24.65万 - 项目类别:
A novel innate immunity risk factor for amyotrophic lateral sclerosis
肌萎缩侧索硬化症的新先天免疫危险因素
- 批准号:
10006773 - 财政年份:2019
- 资助金额:
$ 24.65万 - 项目类别:
Investigation of ALS caused by mutant CHCHD10
CHCHD10 突变体引起的 ALS 的研究
- 批准号:
9220407 - 财政年份:2016
- 资助金额:
$ 24.65万 - 项目类别:
Investigation of ALS caused by mutant CHCHD10
CHCHD10 突变体引起的 ALS 的研究
- 批准号:
9751413 - 财政年份:2016
- 资助金额:
$ 24.65万 - 项目类别:
Investigation of ALS caused by mutant CHCHD10
CHCHD10 突变体引起的 ALS 的研究
- 批准号:
9983200 - 财政年份:2016
- 资助金额:
$ 24.65万 - 项目类别:
Association of ALS to gene-environment mediated changes in HDL proteins
ALS 与基因环境介导的 HDL 蛋白变化的关联
- 批准号:
8760313 - 财政年份:2013
- 资助金额:
$ 24.65万 - 项目类别:
Association of ALS to gene-environment mediated changes in HDL proteins
ALS 与基因环境介导的 HDL 蛋白变化的关联
- 批准号:
8609030 - 财政年份:2013
- 资助金额:
$ 24.65万 - 项目类别:
Association of ALS to gene-environment mediated changes in HDL proteins
ALS 与基因环境介导的 HDL 蛋白变化的关联
- 批准号:
8960824 - 财政年份:2013
- 资助金额:
$ 24.65万 - 项目类别:
Role of High Density Lipoprotein Particles in amyotrophic lateral sclerosis
高密度脂蛋白颗粒在肌萎缩侧索硬化症中的作用
- 批准号:
8469190 - 财政年份:2012
- 资助金额:
$ 24.65万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Transcriptional regulation over neurogenesis of cortical output neuron segmental identity and diversity
皮质输出神经元节段同一性和多样性的神经发生的转录调控
- 批准号:
10638147 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
The Impact of Beta- and Gamma-synucleins on Alpha-synuclein's Synaptic Function
β 和 γ 突触核蛋白对 α 突触核蛋白突触功能的影响
- 批准号:
10830522 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
A novel mitochondria-to-lysosome stress signaling pathway in degenerative disease and aging
退行性疾病和衰老中一种新的线粒体到溶酶体应激信号通路
- 批准号:
10722759 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Unraveling the Mechanisms of Neurodegeneration in TBCK Encephaloneuronopathy
揭示 TBCK 脑神经病神经变性的机制
- 批准号:
10700602 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别: